Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-κB activation

Oncogene

Volumn 15, Issue 15, 1997, Pages 1851-1858

  Floettmann, J E ^a   Rowe, M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

EBV; LMP1; NF B; Signaling; TNF receptor; TRAF

Indexed keywords

CD2 ANTIGEN; CELL SURFACE RECEPTOR; CHIMERIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RECEPTOR PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CROSS LINKING; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INDUCTION; TRANSACTIVATION;

HUMAN HERPESVIRUS 4;

EID: 0030688990     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201359     Document Type: Article

References (46)

1. Ansieau S, Scheffrahn I, Mosialos G, Brand H, Duyster J, Kaye K, Harada J, Dougall B, Hubinger G, Kieff E, Herrmann F, Leutz A and Gruss HJ. (1996). Proc. Natl. Acad. Sci. USA, 93, 14053-14058.
2. Arenzana-Seisdedos F, Fernandez B, Dominguez I, Jacque JM, Thomas D, Diaz-Meco MT, Moscat J and Virelizier JL. (1993). J. Virol., 67, 6596-6604.
3. Baichwal VR and Sugden B. (1988). Oncogene, 2, 461-467.
4. Ben-Basset H, Goldblum N, Mitrani S, Goldblum T, Yoffey JM, Cohey MM, Bentwich Z, Ramot B, Klein E and Klein G. (1977). Int. J. Cancer, 19, 27-33.
5. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH and Wallach D. (1995). J. Biol. Chem., 270, 7795-7798.
6. Brattsand G, Cantrell DA, Ward S, Ivars F and Gullberg M. (1990). J. Immunol., 144, 3651-3658.
7. Cheng G and Baltimore D. (1996). Genes & Dev., 10, 963-973.
8. Clark SJ, Law DA, Paterson DJ, Puklavec M and Williams AF. (1988). J. Exp. Med., 167, 1861-1872.
9. Cohen J, Wang F, Mannick J and Kieff E. (1989). Proc. Natl. Acad Sci. USA, 86, 9558-9562.
10. Devergne O, Hatzivassiliou E, Izumu KM, Kaye KM, Kleijnen MF, Kieff E and Mosialos G. (1996). Mol. Cell. Biol., 16, 7098-7108.
11. Eliopoulos A, Stack M, Dawson C, Kaye K, Rowe M and Young L. (1997). Oncogene, 14, (in press).
12. Floettmann JE, Ward K, Rickinson AB and Rowe M. (1996). Virology, 223, 29-40.
13. Franken M, Devergne O, Rosenzweig M, Annis B, Kieff E and Wang F. (1996). J. Virol., 70, 7819-7826.
14. Hammerschmidt W and Sugden B. (1989). Nature, 340, 393-397.
15. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E and Rickinson A. (1991). Cell. 65, 1107-1115.
16. Herrero JA, Mathew P and Paya CV. (1995). J. Virol., 69, 2168-2174.
17. Hsu H, Xiong J and Goeddel D. (1995). Cell, 81, 495-504.
18. Huen DS, Henderson SA, Croom-Carter D and Rowe M. (1995). Oncogene, 10, 549-560.
19. Jefferies WA, Green JR and Williams AF. (1985). J. Exp. Med., 162, 117-127.
20. Kaye KM, Devergne O, Harada JN, Izumi KM, Yalamanchili R, Kieff E and Mosialos G. (1996). Proc Natl. Acad. Sci. USA, 93, 11085-11090.
21. Kaye KM, Izumi KM and Kieff E. (1993). Proc. Natl. Acad. Sci. USA, 90, 9150-9154.
22. Kieff E. (1996). Fields Virology, Vol. 2. Fields, BN, Knipe DM and Howley PM (eds). Lippincott-Raven Publishers: Philadelphia, pp. 2343-2396.
23. Laherty CD, Hu HM, Opipari AW, Wang F and Dixit VM. (1992). J. Biol. Chem., 267, 24157-24160.
24. Lee SY, Lee SY and Choi Y. (1997). J. Exp. Med., 185, 1275-1285.
25. Lee SY, Lee SY, Kandala G, Liou ML, Lion HC and Choi Y. (1996). Proc. Natl. Acad. Sci. USA, 93, 9699-9703.
26. Miller WE, Edwards RH, Walling DM and Raab-Traub N. (1994). J. Gen. Virol., 75, 2729-2740.
27. Mitchell T and Sugden B. (1995). J. Virol., 69, 2968-2976.
28. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C and Kieff E. (1995). Cell, 80, 389-399.
29. Paine E, Scheinman AS, Baldwin Jr, AS and Raab-Traub N. (1995). J. Virol., 69, 4572-4576.
30. Palefsky JM, Berline J, Penaranda ME, Lennette ET, Greenspan D and Greenspan JS. (1996). J. Infect. Dis., 173, 710-714.
31. Peng M and Lundgren E. (1992). Oncogene, 7, 1775-1782.
32. Pilon M, Gullberg M and Lundgren E. (1991). J. Immunol., 146, 1047-1051.
33. Rickinson AB and Kieff E. (1996). Fields Virology, Vol. 2. Fields BN, Knipe DM and Howley PM (eds). Lippincott-Raven Publishers: Philadelphia, pp. 2397-2446.
34. Robertson ES and Kieff ED. (1995). EBV Report, 2, 73-80.
35. Rothe M, Ming-Gui P, Henzel WJ, Ayres TM and Goeddel DV. (1995). Cell, 83, 1243-1252.
36. Rowe M, Evans HS, Young LS, Hennessy K, Kieff E and Rickinson A. (1987a). J. Gen. Virol., 68, 1575-1586.
37. Rowe M, Peng-Pilon M, Huen DS, Hardy R, Croom-Carter D, Lundgren E and Rickinson AB. (1994). J. Virol., 68, 5602-5612.
38. Rowe M, Rowe DT, Gregory C-D, Young LS, Farrell PJ, Rupani H and Rickinson AB. (1987b). EMBO J., 6, 2743-2751.
39. Sandberg M, Hammerschmidt W and Sugden B. (1997). J. Virol., 71, 4649-4656.
40. Schulze-Osthoff K, Krammer PH and Droge W. (1994). EMBO J., 13, 4587-4596.
41. Stanger BZ, Leder P, Lee TH, Kim E and Seed B. (1995). Cell, 81, 513-523.
42. Wang D, Liebowitz D and Kieff D. (1985). J. Virol., 43, 831-840.
43. Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T and Kieff E. (1988). J. Virol., 62, 4173-4184.
44. Wang F, Gregory C, Sample C, Rowe M, Liebowitz, D, Murray R, Rickinson A and Kieff E. (1990). J. Virol., 64, 2309-2318.
45. Wang S, Rowe M and Lundgren E. (1996). Cancer Res., 56, 4610-4613.
46. Young DC, Kingsley SD, Ryan KA and Dutko FJ. (1993). Anal. Biochem., 215, 24-30.